UK markets close in 1 hour 4 minutes

Sage Therapeutics, Inc. (SG7.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
10.91-0.23 (-2.06%)
As of 03:51PM CEST. Market open.
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts20202020
Avg. Estimate-1.88-1.99-7.33-6.09
Low estimate-1.98-2.19-7.63-9.62
High estimate-1.67-1.74-6.91-1.28
Year ago EPS-2.0318.1911.43-7.33
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts20202122
Avg. Estimate1.97M2.49M7.86M97.32M
Low estimate1.6M1.61M6.4M7.44M
High estimate2.9M5.11M12.22M511.68M
Year ago sales1.64M1.11B1.11B7.86M
Sales growth (year/est)20.20%-99.80%-99.30%1,138.20%
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS-2.39-0.35-1.91-1.69
Actual EPS-2.0318.19-1.64-1.83
Difference0.3618.540.27-0.14
Surprise %15.10%5,297.10%14.10%-8.30%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-1.88-1.99-7.33-6.09
7 days ago-1.88-1.99-7.32-6.05
30 days ago-1.88-1.99-7.32-6.05
60 days ago-1.79-1.87-6.99-5.62
90 days ago-1.79-1.87-6.99-5.58
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesSG7.FIndustrySector(s)S&P 500
Current qtr.7.40%N/AN/AN/A
Next qtr.-110.90%N/AN/AN/A
Current year-164.10%N/AN/AN/A
Next year16.90%N/AN/AN/A
Next 5 years (per annum)41.10%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A